Orin S Levine

Summary

Affiliation: Johns Hopkins Bloomberg School of Public Health
Country: USA

Publications

  1. pmc The Pneumonia Etiology Research for Child Health Project: a 21st century childhood pneumonia etiology study
    Orin S Levine
    Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, USA
    Clin Infect Dis 54:S93-101. 2012
  2. pmc Sequelae due to bacterial meningitis among African children: a systematic literature review
    Meenakshi Ramakrishnan
    BMC Med 7:47. 2009
  3. doi request reprint Global status of Haemophilus influenzae type b and pneumococcal conjugate vaccines: evidence, policies, and introductions
    Orin S Levine
    Department of International Health, Johns Hopkins Bloomberg School of Public Health, International Vaccine Access Center, Baltimore, Maryland, USA
    Curr Opin Infect Dis 23:236-41. 2010
  4. pmc A policy framework for accelerating adoption of new vaccines
    Orin S Levine
    International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
    Hum Vaccin 6:1021-4. 2010
  5. ncbi request reprint Pneumococcal vaccination and public health
    Orin S Levine
    GAVI s PneumoADIP, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    Lancet 369:1144-5. 2007
  6. doi request reprint The future of immunisation policy, implementation, and financing
    Orin S Levine
    Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    Lancet 378:439-48. 2011
  7. ncbi request reprint Pneumococcal vaccination in developing countries
    Orin S Levine
    Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    Lancet 367:1880-2. 2006
  8. ncbi request reprint PneumoADIP: an example of translational research to accelerate pneumococcal vaccination in developing countries
    Orin S Levine
    Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    J Health Popul Nutr 22:268-74. 2004
  9. doi request reprint Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates
    James P Watt
    Hib Initiative, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
    Lancet 374:903-11. 2009
  10. pmc Evaluation of risk factors for severe pneumonia in children: the Pneumonia Etiology Research for Child Health study
    Chizoba B Wonodi
    International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, 21205, USA
    Clin Infect Dis 54:S124-31. 2012

Detail Information

Publications33

  1. pmc The Pneumonia Etiology Research for Child Health Project: a 21st century childhood pneumonia etiology study
    Orin S Levine
    Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, USA
    Clin Infect Dis 54:S93-101. 2012
    ..PERCH will also address differences in host, environmental, and/or geographic factors that might determine pneumonia etiology and, by preserving specimens, will generate a resource for future research and pathogen discovery...
  2. pmc Sequelae due to bacterial meningitis among African children: a systematic literature review
    Meenakshi Ramakrishnan
    BMC Med 7:47. 2009
    ..The objective of this study is to present a comprehensive review of data on bacterial meningitis sequelae in children from the African continent...
  3. doi request reprint Global status of Haemophilus influenzae type b and pneumococcal conjugate vaccines: evidence, policies, and introductions
    Orin S Levine
    Department of International Health, Johns Hopkins Bloomberg School of Public Health, International Vaccine Access Center, Baltimore, Maryland, USA
    Curr Opin Infect Dis 23:236-41. 2010
    ..This study reviews the status of vaccine use globally and the evidence base that supports policy recommendations for use of these vaccines in children...
  4. pmc A policy framework for accelerating adoption of new vaccines
    Orin S Levine
    International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
    Hum Vaccin 6:1021-4. 2010
    ..It highlights the important roles of different actors at various times in the process and may allow new vaccine initiatives to save time and improve their efficiency by anticipating key steps and actions...
  5. ncbi request reprint Pneumococcal vaccination and public health
    Orin S Levine
    GAVI s PneumoADIP, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    Lancet 369:1144-5. 2007
  6. doi request reprint The future of immunisation policy, implementation, and financing
    Orin S Levine
    Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    Lancet 378:439-48. 2011
    ..Novel methods are needed to finance the increasing number of new vaccines that have the potential to save lives in countries that are too poor to afford them. Here, we discuss some options...
  7. ncbi request reprint Pneumococcal vaccination in developing countries
    Orin S Levine
    Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    Lancet 367:1880-2. 2006
  8. ncbi request reprint PneumoADIP: an example of translational research to accelerate pneumococcal vaccination in developing countries
    Orin S Levine
    Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    J Health Popul Nutr 22:268-74. 2004
    ..This model may provide a useful example and valuable lessons for how a successful public-private partnership can improve global health...
  9. doi request reprint Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates
    James P Watt
    Hib Initiative, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
    Lancet 374:903-11. 2009
    ..Hib disease can be almost completely eliminated through routine vaccination. We assessed the global burden of disease to help national policy makers and international donors set priorities...
  10. pmc Evaluation of risk factors for severe pneumonia in children: the Pneumonia Etiology Research for Child Health study
    Chizoba B Wonodi
    International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, 21205, USA
    Clin Infect Dis 54:S124-31. 2012
    ....
  11. doi request reprint Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates
    Katherine L O'Brien
    GAVI s PneumoADIP, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
    Lancet 374:893-902. 2009
    ..To support local and global policy decisions on pneumococcal disease prevention and treatment, we estimated country-specific incidence of serious cases and deaths in children younger than 5 years...
  12. pmc A literature review and survey of childhood pneumonia etiology studies: 2000-2010
    Zunera Gilani
    Department of Epidemiology, Bloomberg School of Public Health, Baltimore, MD 21205, USA
    Clin Infect Dis 54:S102-8. 2012
    ..It reinforces the need for the standardization of methods and analyses for present and future pneumonia etiology studies in order to optimize their cumulative potential to accurately describe the microbial causes of childhood pneumonia...
  13. pmc Identification and selection of cases and controls in the Pneumonia Etiology Research for Child Health project
    Maria Deloria-Knoll
    International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, USA
    Clin Infect Dis 54:S117-23. 2012
    ..For each issue, we present the options that were considered, the advantages and disadvantages of each, the rationale for the methods selected for PERCH, and remaining implications and limitations...
  14. doi request reprint Estimated economic benefits during the 'decade of vaccines' include treatment savings, gains in labor productivity
    Meghan L Stack
    Department of International Health at the Johns Hopkins Bloomberg School of Public Health, in Baltimore, Maryland, USA
    Health Aff (Millwood) 30:1021-8. 2011
    ..Monetary estimates based on this type of analysis can be used to determine the return on investment in immunization from both the international community and local governments, and they should be considered in policy making...
  15. doi request reprint Standardizing surveillance of pneumococcal disease
    Maria Deloria Knoll
    GAVI Alliance s Pneumococcal Vaccines Accelerated Development and Introduction Plan, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, USA
    Clin Infect Dis 48:S37-48. 2009
    ..To facilitate comparisons of surveillance data among countries, investigators of Pneumococcal Vaccines Accelerated Development and Introduction Plan-sponsored projects have developed standard case definitions and data reporting methods...
  16. ncbi request reprint Haemophilus influenzae type b conjugate vaccines: considerations for vaccination schedules and implications for developing countries
    Sean P Fitzwater
    Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
    Hum Vaccin 6:810-8. 2010
    ..Here, we present a synthesis of data supporting various Hib vaccine schedules, with a focus on the implications for developing countries...
  17. ncbi request reprint Global reduction of Hib disease: what are the next steps? Proceedings of the meeting Scottsdale, Arizona, September 22-25, 2002
    James P Watt
    Department of International Health, the Center for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
    J Pediatr 143:S163-87. 2003
    ..In areas where Hib disease burden is not well characterized, additional work will be needed to understand the epidemiology of Hib disease and to communicate the value of Hib conjugate vaccine...
  18. doi request reprint Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review
    Sachiko Ozawa
    Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, United States
    Vaccine 31:96-108. 2012
    ..As vaccine costs rise and competing priorities increase, economic evidence is likely to play an increasingly important role in vaccination decisions...
  19. pmc Spatial and socio-demographic predictors of time-to-immunization in a rural area in Kenya: Is equity attainable?
    Jennifer C Moïsi
    Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
    Vaccine 28:5725-30. 2010
    ..Travel time did not affect vaccination coverage or timeliness. The Kenyan EPI reaches nearly all children in Kilifi and delays in vaccination are few, suggesting that vaccines will have maximal impact on child morbidity and mortality...
  20. pmc Specimen collection for the diagnosis of pediatric pneumonia
    Laura L Hammitt
    International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, USA
    Clin Infect Dis 54:S132-9. 2012
    ..We discuss the advantages and limitations of each specimen, and discuss the rationale for the specimens to be collected for the Pneumonia Etiology Research for Child Health study...
  21. ncbi request reprint The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease
    Sandra J Bliss
    Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA
    Lancet Infect Dis 8:67-80. 2008
    ..PCV should be considered as an important intervention for improving the lives of HIV-infected children...
  22. doi request reprint During the 'decade of vaccines,' the lives of 6.4 million children valued at $231 billion could be saved
    Sachiko Ozawa
    Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
    Health Aff (Millwood) 30:1010-20. 2011
    ..It highlights the major economic benefits made possible by improving vaccine coverage...
  23. pmc Enhanced diagnosis of pneumococcal meningitis with use of the Binax NOW immunochromatographic test of Streptococcus pneumoniae antigen: a multisite study
    Jennifer C Moïsi
    GAVI Alliance s PneumoADIP, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD 21205, USA
    Clin Infect Dis 48:S49-56. 2009
    ..Cerebrospinal fluid (CSF) culture and latex agglutination testing are currently the standard diagnostic methods but lack sensitivity...
  24. pmc Geographic access to care is not a determinant of child mortality in a rural Kenyan setting with high health facility density
    Jennifer C Moïsi
    Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
    BMC Public Health 10:142. 2010
    ..Distance to health facilities is a known determinant of health care utilization and may drive inequalities in health outcomes; we aimed to investigate its effects on childhood mortality...
  25. pmc Sensitivity of hospital-based surveillance for severe disease: a geographic information system analysis of access to care in Kilifi district, Kenya
    Jennifer C Moïsi
    KEMRI Wellcome Trust Research Programme, Kilifi, Kenya
    Bull World Health Organ 89:102-11. 2011
    ..To explore the relationship between homestead distance to hospital and access to care and to estimate the sensitivity of hospital-based surveillance in Kilifi district, Kenya...
  26. ncbi request reprint Effectiveness of pneumococcal conjugate vaccine
    Katherine L O'Brien
    Center for American Indian Health, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    Lancet 368:1469-70. 2006
  27. doi request reprint Higher pneumococcal disease vaccination rates needed to protect more at-risk US adults
    Susan J Rehm
    National Foundation for Infectious Diseases, Bethesda, MD, USA
    Postgrad Med 121:101-5. 2009
    ....
  28. ncbi request reprint Pneumococcal disease and vaccination in the Americas: an agenda for accelerated vaccine introduction
    Salvador Garcia
    The Pan American Health Organization, Washington, DC, United States of America
    Rev Panam Salud Publica 19:340-8. 2006
    ....
  29. ncbi request reprint The changing landscape of epidemic bacterial meningitis in Africa: new opportunities for prevention
    Jay C Butler
    J Infect Dis 192:189-91. 2005
  30. ncbi request reprint Impact of haemophilus influenzae type b conjugate vaccine in South Africa and Argentina
    Michael Martin
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Pediatr Infect Dis J 23:842-7. 2004
    ..Because surveillance for culture-confirmed Hib meningitis is not available in many countries, alternative means to measure the impact of Hib conjugate vaccine would be useful...
  31. pmc Vaccines to prevent pneumonia and improve child survival
    Shabir A Madhi
    Department of Science and Technology, National Research Foundation, Vaccine Preventable Diseases, Chris Hani Baragwanth Hospital, University of the Witwatersrand, Bertsham, South Africa
    Bull World Health Organ 86:365-72. 2008
    ..In this review, we discuss advances made in optimizing the use of established vaccines and the potential issues related to newer bacterial conjugate vaccines in reducing childhood pneumonia morbidity and mortality...
  32. pmc Rapid assessment tool for Haemophilus influenzae type b disease in developing countries
    Daniel R Feikin
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 10:1270-6. 2004
    ..Results were affected by the quality of available data. The Hib rapid assessment tool can be useful to countries that desire a timely assessment of Hib disease rates...
  33. ncbi request reprint Pneumococcal vaccination for Indian children
    Orin S Levine
    Indian Pediatr 44:491-6. 2007